<DOC>
	<DOCNO>NCT00048776</DOCNO>
	<brief_summary>Juvenile secondary Raynaud ’ ( ray-knows ) Phenomenon disorder blood vessel finger sometimes affect toe , nose , ear . Children secondary Raynaud ’ Phenomenon underlie condition systemic lupus , scleroderma , mixed connective tissue disease . When child secondary Raynaud ’ expose chilly cold condition weather , cold temperature , even hold cold item refrigerator , finger may become cold , numb , hurt , and/or turn purple white . The investigational drug , Pletal ( cilostazol ) , approve condition , inhibits ability one type blood cell , platelet , form blood clot , also widen narrowed blood vessel . It use variety condition blood flow decrease . This study test safety effectiveness Pletal ( cilostazol ) lessen severity symptom decrease number secondary Raynaud ’ episode juvenile patient .</brief_summary>
	<brief_title>Safety Efficacy Pletal ( Cilostazol ) Treatment Juvenile Primary Secondary Raynaud ’ Phenomenon</brief_title>
	<detailed_description />
	<mesh_term>Raynaud Disease</mesh_term>
	<mesh_term>Cilostazol</mesh_term>
	<criteria>Inclusion Criteria 5 16 year old fulfill diagnostic criterion primary secondary Raynaud 's</criteria>
	<gender>All</gender>
	<minimum_age>5 Years</minimum_age>
	<maximum_age>16 Years</maximum_age>
	<verification_date>July 2005</verification_date>
	<keyword>Secondary Raynaud 's</keyword>
	<keyword>circulatory</keyword>
	<keyword>vascular</keyword>
	<keyword>scleroderma</keyword>
	<keyword>lupus</keyword>
	<keyword>mixed connective tissue disease</keyword>
</DOC>